Spots Global Cancer Trial Database for antibodies
Every month we try and update this database with for antibodies cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors | NCT01081808 | Neoplasms Tumors Solid Tumors Metastatic Canc... | EGFRBi-armed au... | 18 Years - | Roger Williams Medical Center | |
| Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma | NCT03336606 | Head and Neck C... Head and Neck S... Melanoma Cell Cancer, Sq... Carcinoma, Squa... | MEDI0562 | 18 Years - | Providence Health & Services | |
| Blood Test for Ovarian Cancer Associated Antibodies (CAAb) | NCT00327925 | Ovarian Cancer | Find Cancer Ass... | 18 Years - | Lab Discoveries Ltd. | |
| Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine | NCT03542227 | Human Papilloma... | First-void urin... Blood draw | 16 Years - 55 Years | Universiteit Antwerpen | |
| A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies | NCT03922204 | Advanced Cancer Solid Tumor, Ad... B-cell Lymphoma... | MCLA-145 | 18 Years - | Merus N.V. | |
| Blood Test for Ovarian Cancer Associated Antibodies (CAAb) | NCT00327925 | Ovarian Cancer | Find Cancer Ass... | 18 Years - | Lab Discoveries Ltd. | |
| FLYSYN in MRD Positive AML | NCT02789254 | Acute Myeloid L... | FLYSYN | 18 Years - | Synimmune GmbH | |
| Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors | NCT01081808 | Neoplasms Tumors Solid Tumors Metastatic Canc... | EGFRBi-armed au... | 18 Years - | Roger Williams Medical Center | |
| First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer | NCT01723475 | Prostatic Neopl... | BAY2010112 BAY2010112 | 18 Years - | Bayer | |
| Extended Treatment Access Study of MT-3724 for Subjects With Relapsed Non-Hodgkin's B-Cell Lymphoma | NCT02715843 | Non-Hodgkin's B... | MT-3724 | 18 Years - | Molecular Templates, Inc. | |
| A Drug Monitoring Study on PEG-asparaginase Treatment in Children Diagnosed Acute Lymphoblastic Leukaemia | NCT01272440 | Acute Lymphobla... | 1 Year - 18 Years | Aarhus University Hospital | ||
| ADC-1013 First-in-Human Study | NCT02379741 | Neoplasms Solid Tumors | ADC-1013 | 18 Years - | Alligator Bioscience AB | |
| Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC) | NCT04938609 | Head and Neck C... Head and Neck S... | Pembrolizumab Stereotactic Bo... Surgical Resect... | 18 Years - | Providence Health & Services | |
| Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma | NCT03336606 | Head and Neck C... Head and Neck S... Melanoma Cell Cancer, Sq... Carcinoma, Squa... | MEDI0562 | 18 Years - | Providence Health & Services | |
| AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer | NCT01287130 | Colonic Neoplas... Cancer of the C... Colon Cancer Colon Neoplasms Colonic Cancer | Cetuximab AZD6244 | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphocytic Lymphoma | NCT02556346 | Chronic B-cell ... Small Lymphocyt... | MT-3724 MT-3724 MT-3724 MT-3724 MT-3724 | 18 Years - | Molecular Templates, Inc. | |
| Extended Treatment Access Study of MT-3724 for Subjects With Relapsed Non-Hodgkin's B-Cell Lymphoma | NCT02715843 | Non-Hodgkin's B... | MT-3724 | 18 Years - | Molecular Templates, Inc. | |
| Breast Cancer Associated Antibodies | NCT00331942 | Breast Cancer | 18 Years - | Lab Discoveries Ltd. | ||
| Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL | NCT02361346 | Non-Hodgkin's B... Leukemia, Lymph... Small Lymphocyt... Diffuse Large B... Blood Cancer Hematological M... | MT-3724 Phase 1 MT-3724 Phase 2 | 18 Years - | Molecular Templates, Inc. | |
| FLYSYN in MRD Positive AML | NCT02789254 | Acute Myeloid L... | FLYSYN | 18 Years - | Synimmune GmbH | |
| Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System | NCT04743388 | COVID-19 Healthy Volunte... Chronic Disease Hematological M... Solid Tumor | BNT162b2 Other vaccine a... | 18 Years - | National and Kapodistrian University of Athens | |
| GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL) | NCT01419665 | Follicular Lymp... | GP2013 rituximab | 18 Years - | Sandoz | |
| COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients | NCT05054218 | Covid19 SARS-CoV2 Infec... | mRNA-1273 | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma | NCT01659151 | Metastatic Mela... | High Dose Inter... ACT with TIL In... Vemurafenib Lymphodepletion | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL) | NCT01419665 | Follicular Lymp... | GP2013 rituximab | 18 Years - | Sandoz | |
| Blood Test for Ovarian Cancer Associated Antibodies (CAAb) | NCT00327925 | Ovarian Cancer | Find Cancer Ass... | 18 Years - | Lab Discoveries Ltd. | |
| A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies | NCT03922204 | Advanced Cancer Solid Tumor, Ad... B-cell Lymphoma... | MCLA-145 | 18 Years - | Merus N.V. | |
| Neoadjuvant Immunoradiotherapy in Head & Neck Cancer | NCT03247712 | Head and Neck C... Head and Neck S... | Nivolumab Surgical Resect... Radiation (5 da... Radiation (3 da... | 18 Years - | Providence Health & Services | |
| Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy | NCT01384253 | Breast Neoplasm... Peritoneal Neop... Ovarian Neoplas... Pancreatic Neop... Stomach Neoplas... | ²¹²Pb-TCMC-Tras... trastuzumab | 19 Years - | Orano Med LLC | |
| SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma | NCT00365274 | Anaplastic Larg... | Cyclophosphamid... Doxorubicin hyd... vincristine sul... prednisone SGN-30 | 18 Years - | National Cancer Institute (NCI) | |
| First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin | NCT00981058 | Non Small Cell ... | Necitumumab Gemcitabine Cisplatin | 18 Years - | Eli Lilly and Company | |
| Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL | NCT02361346 | Non-Hodgkin's B... Leukemia, Lymph... Small Lymphocyt... Diffuse Large B... Blood Cancer Hematological M... | MT-3724 Phase 1 MT-3724 Phase 2 | 18 Years - | Molecular Templates, Inc. | |
| First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate Cancer | NCT01723475 | Prostatic Neopl... | BAY2010112 BAY2010112 | 18 Years - | Bayer | |
| Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors | NCT01081808 | Neoplasms Tumors Solid Tumors Metastatic Canc... | EGFRBi-armed au... | 18 Years - | Roger Williams Medical Center | |
| Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins | NCT01563874 | Lymphoma Lymphoid Hyperp... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| A Study of Bispecific Antibody MCLA-145 in Patients With Advanced or Metastatic Malignancies | NCT03922204 | Advanced Cancer Solid Tumor, Ad... B-cell Lymphoma... | MCLA-145 | 18 Years - | Merus N.V. | |
| First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin | NCT00982111 | Non Small Cell ... | Pemetrexed Cisplatin Necitumumab | 18 Years - | Eli Lilly and Company | |
| A Drug Monitoring Study on PEG-asparaginase Treatment in Children Diagnosed Acute Lymphoblastic Leukaemia | NCT01272440 | Acute Lymphobla... | 1 Year - 18 Years | Aarhus University Hospital | ||
| CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and Tremelimumab | NCT03638141 | Intermediate St... Hepatocellular ... | Durvalumab Tremelimumab (C... Tremelimumab (C... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin | NCT00981058 | Non Small Cell ... | Necitumumab Gemcitabine Cisplatin | 18 Years - | Eli Lilly and Company | |
| Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma | NCT01496807 | Melanoma | Sylatron Yervoy | 16 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Novel Adjuvants for Peptide-Based Melanoma Vaccines | NCT00028431 | Melanoma | MDX-CTLA4 Antib... | 18 Years - | University of Southern California | |
| Breast Cancer Associated Antibodies | NCT00331942 | Breast Cancer | 18 Years - | Lab Discoveries Ltd. | ||
| Effect of Vaccination in Patients With Recurrent Respiratory Papillomatosis | NCT01375868 | Squamous Papill... | Silgard | 18 Years - | Institute of Hematology and Blood Transfusion, Czech Republic | |
| Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphocytic Lymphoma | NCT02556346 | Chronic B-cell ... Small Lymphocyt... | MT-3724 MT-3724 MT-3724 MT-3724 MT-3724 | 18 Years - | Molecular Templates, Inc. | |
| Proteomic-Based Profiling of Lymphomas: Chromatin Proteomics; Composition and Modification of Histone and Non-Histone Chromosomal Proteins | NCT01563874 | Lymphoma Lymphoid Hyperp... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
| Study of AGEN2034 in Advanced Tumors and Cervical Cancer | NCT03104699 | Advanced Cancer Cervical Cancer | AGEN2034 | 18 Years - | Agenus Inc. | |
| A Study of BMS-986249 Alone and in Combination With Nivolumab in Advanced Solid Tumors | NCT03369223 | Advanced Cancer | BMS-986249 Nivolumab Ipilimumab | 18 Years - | Bristol-Myers Squibb |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
